Sam S Ahn, MD
Allergy/Immunology · Napa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 23 years
- Harvard Medical School, 2003
Offices
1 location · North Bay Allergy and Asthma · 3 clinicians in this group
Hospitals listed: John Muir Medical Center - Walnut Creek Campus · Providence Queen of the Valley Medical Center · Sonoma Valley Hospital. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ahn’s office at (707) 258-8100 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence C147289 · Current
Licensed to practise in California · since 2017 · expires 2027-02-28 · Harvard Medical School.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Allergy and Immunology - Allergy and Immunology
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- John Muir Medical Center - Walnut Creek CampusWalnut Creek, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 2.01 (1.17 to 2.85) · 2,206 cases, Jul 2022 – Jun 2024Worse than the national rate — Death rate among surgical inpatients with serious treatable complications: 222.42 (177.82 to 267.02) · 120 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.4 (0.91 to 1.9) · 9,764 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 2.734, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.536, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.341, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.455, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.245, Oct 2024 – Sep 2025
- Providence Queen of the Valley Medical CenterNapa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.107, Oct 2024 – Sep 2025
- Sonoma Valley HospitalSonoma, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for John Muir Medical Center - Walnut Creek Campus
Behind the star rating — Deaths: 3 better, 2 the same, 2 worse of 7 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 3 better, 5 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2.01 (1.17 to 2.85) · 2,206 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 222.42 (177.82 to 267.02) · 120 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.4 (0.91 to 1.9) · 9,764 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 2.734 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.536 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.341 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.455 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.245 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.87 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 131 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.5 · 827 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.1 · 509 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 4,483 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.18 to 0.53) · 11,630 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.05 to 0.39) · 11,793 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.69 to 4.96) · 3,268 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.94) · 1,631 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.76 (1.43 to 4.09) · 3,066 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.12 (0.22 to 12.02) · 1,580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.43 (1.21 to 7.64) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 685 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 615 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.88 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 93 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 729 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13 · 736 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.8 · 842 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 818 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.4) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.2 to 15.5) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 584 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.9) · 222 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 321 cases | No different | Jan 2024 – Dec 2024 |
What patients said (758 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Providence Queen of the Valley Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.107 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.92) · 609 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.5 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 191.43 (130.54 to 252.33) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12 · 271 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.7 · 376 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 175 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 1,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.41) · 4,152 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,188 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.81 (1.63 to 5.99) · 803 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.21) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.19 (0.62 to 3.77) · 742 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.45 (0.91 to 16) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.58 (1.75 to 9.42) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 152 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.19 (0 to 0.94) · 2,994 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.684 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.887 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 270 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.8 · 143 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.1 · 316 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -1 · 399 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20.4 · 337 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.5 to 7.8) · 107 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (9.8 to 17.7) · 107 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.4 to 16.2) · 848 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 423 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 40% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for Sonoma Valley Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 6 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.11 (0.63 to 1.6) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 37 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.6 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 35 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.6 · 345 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 713 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.36 (0.77 to 5.94) · 101 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.38) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.58 to 4.03) · 100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.86 (0 to 18.76) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (0.84 to 9.45) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.12 (0 to 2.33) · 540 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 60 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.5 · 47 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 105 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.2 to 17.9) · 486 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 83 cases | No different | Jan 2024 – Dec 2024 |
What patients said (164 patients answered, 31% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 85% |
| Doctors "always" communicated well | 88% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 84% |
| Doctors "always" listened carefully | 88% |
| Doctors "always" treated them with courtesy and respect | 92% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 81% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$717,627
Medicare paid this office $717,627 for 544 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, omalizumab, 5 mg | 23 | $408,697 | None |
| Test for allergy using allergenic extract | 162 | $27,734 | $3 |
| Short return visit (20+ min) | 297 | $27,380 | $68 |
| Return visit (30+ min) | 99 | $17,123 | $94 |
| New patient visit (30+ min) | 202 | $16,482 | $82 |
See all 15 services
| Injection, omalizumab, 5 mg | 23 | $408,697 | None |
| Test for allergy using allergenic extract | 162 | $27,734 | $3 |
| Short return visit (20+ min) | 297 | $27,380 | $68 |
| Return visit (30+ min) | 99 | $17,123 | $94 |
| New patient visit (30+ min) | 202 | $16,482 | $82 |
| Professional service for preparation and provision of 1 or more antigens | 109 | $15,137 | $12 |
| Professional service for multiple injections of allergen | 107 | $14,902 | $10 |
| Test for allergy using allergenic extract injected into skin | 118 | $8,754 | $7 |
| Injection of drug or substance under skin or into muscle | 49 | $8,449 | $11 |
| Influenza vaccine split virus, preservative free | 58 | $4,746 | $82 |
| Test to measure the level of nitric oxide gas | 157 | $3,612 | $16 |
| Test to measure rate of airflow | 88 | $2,931 | $29 |
| Professional service for single injection of allergen | 30 | $2,849 | $8 |
| Administration of influenza virus vaccine | 61 | $2,172 | $36 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 51 | $1,092 | $19 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Diagnostic exam of nasal passages using an endoscope | 14 | – | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
544 Original Medicare patients in 2024. Average age 73 · Under 65 9% · 85 and older 7% · Women 68% · Also on Medicaid 14% · Health risk score 0.93. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 1.
Conditions among them: High blood pressure 63% · Diabetes 19% · Coronary heart disease 17% · Cancer 16% · Depression 15% · Chronic kidney disease 13% · Atrial fibrillation 13% · COPD 11% · Heart failure 9% · Stroke 5% · Dementia 2%.
The office billed $1,651,621, Medicare allowed $920,579 and paid $717,627; for 37,771 services of 35 kinds; $560,774 of it was for drugs given in the office and $156,853 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 544 | 37,771 | 73 | 0.93 | $1,651,621 | $717,627 |
| 2023 | 505 | 39,431 | 73 | 0.89 | $1,448,787 | $740,759 |
| 2022 | 499 | 31,132 | 73 | 0.95 | $1,315,945 | $678,363 |
| 2021 | 573 | 29,273 | 73 | 0.90 | $1,355,151 | $719,814 |
| 2020 | 310 | 13,431 | 71 | 1.00 | $493,240 | $235,032 |
| 2019 | 326 | 15,738 | 71 | 1.03 | $582,836 | $279,754 |
| 2018 | 346 | 15,356 | 71 | 1.01 | $668,540 | $345,706 |
| 2017 | 360 | 10,917 | 73 | 0.95 | $213,107 | $102,444 |
| 2016 | 347 | 16,205 | 73 | 0.92 | $249,270 | $128,141 |
| 2015 | 342 | 14,661 | 72 | 0.88 | $217,739 | $117,391 |
| 2014 | 307 | 14,935 | 72 | 0.80 | $219,739 | $122,677 |
| 2013 | 263 | 11,961 | 72 | 0.83 | $169,384 | $95,401 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Injection, omalizumab, 5 mg | 19 | $337,428 | None |
| Test for allergy using allergenic extract | 154 | $32,378 | $4 |
| Return visit (30+ min) | 118 | $25,732 | $102 |
| Short return visit (20+ min) | 243 | $22,807 | $72 |
| Professional service for preparation and provision of 1 or more antigens | 99 | $16,600 | $14 |
| Professional service for multiple injections of allergen | 98 | $15,253 | $10 |
| New patient visit (30+ min) | 173 | $15,082 | $87 |
| Injection of drug or substance under skin or into muscle | 48 | $8,235 | $12 |
| Test for allergy using allergenic extract injected into skin | 91 | $7,661 | $8 |
| Influenza vaccine split virus, preservative free | 104 | $7,477 | $72 |
| Administration of influenza virus vaccine | 111 | $3,794 | $34 |
| Test to measure the level of nitric oxide gas | 144 | $3,791 | $17 |
| Test to measure rate of airflow | 87 | $3,469 | $33 |
| Professional service for single injection of allergen | 31 | $2,909 | $9 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 54 | $1,130 | $20 |
| Evaluation of use of breathing device | 13 | $219 | $17 |
2022: 18 services
| Injection, omalizumab, 5 mg | 21 | $309,496 | None |
| Test for allergy using allergenic extract | 135 | $29,501 | $4 |
| Return visit (30+ min) | 145 | $28,516 | $106 |
| Short return visit (20+ min) | 240 | $23,424 | $70 |
| Professional service for preparation and provision of 1 or more antigens | 95 | $15,415 | $13 |
| Professional service for multiple injections of allergen | 91 | $12,312 | $10 |
| New patient visit (30+ min) | 144 | $12,265 | $85 |
| Test for allergy using allergenic extract injected into skin | 93 | $8,588 | $8 |
| Injection of drug or substance under skin or into muscle | 55 | $7,784 | $12 |
| Influenza vaccine split virus, preservative free | 93 | $6,374 | $69 |
| Administration of influenza virus vaccine | 97 | $3,257 | $34 |
| Test to measure the level of nitric oxide gas | 145 | $3,065 | $17 |
| Test to measure rate of airflow | 80 | $2,824 | $32 |
| Test for allergy using skin patch | 12 | $2,774 | $5 |
| Professional service for single injection of allergen | 33 | $2,661 | $8 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 40 | $1,076 | $21 |
| Evaluation of use of breathing device | 23 | $326 | $14 |
| Telephone medical discussion provided by nonphysician professional, 5-10 minutes | 16 | $180 | $10 |
2021: 18 services
| Injection, omalizumab, 5 mg | 21 | $318,407 | None |
| Short return visit (20+ min) | 338 | $37,494 | $75 |
| Return visit (30+ min) | 187 | $36,593 | $105 |
| Test for allergy using allergenic extract | 158 | $34,138 | $4 |
| Professional service for preparation and provision of 1 or more antigens | 97 | $16,417 | $14 |
| Professional service for multiple injections of allergen | 99 | $14,534 | $10 |
| New patient visit (30+ min) | 144 | $13,138 | $91 |
| Test for allergy using allergenic extract injected into skin | 99 | $8,349 | $8 |
| Injection of drug or substance under skin or into muscle | 50 | $8,315 | $12 |
| Influenza vaccine split virus, preservative free | 92 | $6,004 | $65 |
| Test for allergy using skin patch | 14 | $4,482 | $5 |
| Professional service for single injection of allergen | 30 | $2,542 | $8 |
| Test to measure the level of nitric oxide gas | 93 | $2,258 | $19 |
| Administration of influenza virus vaccine | 96 | $1,865 | $19 |
| New patient visit (45+ min) | 15 | $1,841 | $123 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 54 | $1,344 | $20 |
| Test to measure rate of airflow | 20 | $618 | $29 |
| Telephone medical discussion provided by nonphysician professional, 5-10 minutes | 18 | $264 | $11 |
2020: 15 services
| Test for allergy using allergenic extract | 102 | $18,934 | $4 |
| Short return visit (20+ min) | 173 | $14,615 | $62 |
| Return visit (30+ min) | 104 | $11,655 | $77 |
| New patient visit (30+ min) | 102 | $8,893 | $87 |
| Professional service for preparation and provision of 1 or more antigens | 48 | $7,214 | $14 |
| Professional service for multiple injections of allergen | 51 | $5,395 | $9 |
| Test for allergy using allergenic extract injected into skin | 59 | $4,269 | $8 |
| Injection of drug or substance under skin or into muscle | 23 | $1,867 | $12 |
| Professional service for single injection of allergen | 13 | $1,697 | $8 |
| Influenza vaccine split virus, preservative free | 16 | $976 | $61 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 28 | $666 | $21 |
| Test to measure rate of airflow | 23 | $506 | $22 |
| Administration of influenza virus vaccine | 18 | $346 | $19 |
| Test to measure the level of nitric oxide gas | 19 | $228 | $12 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 11 | $153 | $13 |
2019: 18 services
| Test for allergy using allergenic extract | 140 | $24,718 | $4 |
| Short return visit (20+ min) | 235 | $23,413 | $61 |
| New patient visit (30+ min) | 143 | $12,076 | $84 |
| Return visit (30+ min) | 72 | $8,834 | $92 |
| Professional service for preparation and provision of 1 or more antigens | 43 | $6,677 | $14 |
| Professional service for multiple injections of allergen | 41 | $5,992 | $9 |
| Test for allergy using allergenic extract injected into skin | 65 | $4,351 | $8 |
| Test to measure rate of airflow | 78 | $4,332 | $34 |
| Diagnostic exam of nasal passages using an endoscope | 14 | $2,689 | $192 |
| Test to measure the level of nitric oxide gas | 76 | $2,247 | $18 |
| Injection of drug or substance under skin or into muscle | 29 | $2,223 | $15 |
| Test for allergy using ingested items, initial 2 hours | 16 | $1,958 | $109 |
| Test for allergy using combination of methods with drug or biological | 14 | $1,815 | $21 |
| Professional service for single injection of allergen | 14 | $1,414 | $8 |
| Influenza vaccine split virus, preservative free | 20 | $1,095 | $55 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 34 | $846 | $21 |
| Administration of influenza virus vaccine | 21 | $398 | $19 |
| Inhalation treatment for airway obstruction or sputum production | 12 | $202 | $16 |
2018: 14 services
| Injection, omalizumab, 5 mg | 14 | $197,961 | None |
| Test for allergy using allergenic extract | 137 | $27,096 | $5 |
| Short return visit (20+ min) | 242 | $24,520 | $60 |
| New patient visit (30+ min) | 167 | $14,284 | $86 |
| Professional service for multiple injections of allergen | 25 | $3,017 | $9 |
| Professional service for preparation and provision of 1 or more antigens | 23 | $3,012 | $13 |
| Injection of drug or substance under skin or into muscle | 27 | $2,726 | $18 |
| Test to measure rate of airflow | 59 | $2,322 | $35 |
| Test to measure the level of nitric oxide gas | 67 | $1,478 | $18 |
| Return visit (30+ min) | 18 | $1,389 | $77 |
| Influenza vaccine split virus, preservative free | 26 | $1,351 | $52 |
| Test for allergy using allergenic extract injected into skin | 18 | $961 | $8 |
| Administration of influenza virus vaccine | 32 | $756 | $24 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $383 | $20 |
2017: 15 services
| Test for allergy using allergenic extract | 97 | $32,513 | $6 |
| Short return visit (20+ min) | 222 | $13,167 | $50 |
| Professional service for preparation and provision of 1 or more antigens | 132 | $12,978 | $8 |
| New patient visit (30+ min) | 97 | $8,114 | $84 |
| Professional service for single injection of allergen | 89 | $5,254 | $5 |
| Professional service for multiple injections of allergen | 76 | $4,497 | $6 |
| Test for allergy using allergenic extract injected into skin | 67 | $3,099 | $6 |
| New patient visit (45+ min) | 18 | $1,901 | $106 |
| Return visit (30+ min) | 19 | $1,723 | $86 |
| Test to measure rate of airflow | 29 | $1,096 | $37 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 22 | $1,009 | $42 |
| Influenza vaccine split virus, preservative free | 14 | $673 | $48 |
| Test to measure the level of nitric oxide gas | 24 | $496 | $18 |
| Administration of influenza virus vaccine | 14 | $417 | $30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $125 | None |
2016: 12 services
| Test for allergy using allergenic extract | 103 | $42,244 | $5 |
| Professional service for preparation and provision of 1 or more antigens | 147 | $27,492 | $9 |
| Short return visit (20+ min) | 251 | $15,929 | $50 |
| Professional service for single injection of allergen | 117 | $12,052 | $6 |
| Professional service for multiple injections of allergen | 80 | $9,003 | $7 |
| New patient visit (45+ min) | 39 | $4,596 | $118 |
| New patient visit (30+ min) | 63 | $4,269 | $68 |
| Test for allergy using allergenic extract injected into skin | 95 | $4,143 | $6 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 29 | $1,352 | $42 |
| Administration of influenza virus vaccine | 52 | $1,293 | $25 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 52 | $817 | $16 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $153 | None |
2015: 11 services
| Test for allergy using allergenic extract | 88 | $34,011 | $5 |
| Professional service for preparation and provision of 1 or more antigens | 149 | $27,766 | $9 |
| Short return visit (20+ min) | 253 | $16,265 | $51 |
| Professional service for single injection of allergen | 128 | $11,967 | $6 |
| Professional service for multiple injections of allergen | 65 | $7,406 | $7 |
| New patient visit (30+ min) | 66 | $4,259 | $65 |
| Test for allergy using allergenic extract injected into skin | 84 | $3,707 | $6 |
| New patient visit (45+ min) | 30 | $3,451 | $115 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 33 | $2,143 | $43 |
| Administration of influenza virus vaccine | 54 | $953 | $18 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 54 | $837 | $16 |
2014: 11 services
| Test for allergy using allergenic extract | 94 | $36,639 | $5 |
| Professional service for preparation and provision of 1 or more antigens | 141 | $27,801 | $9 |
| Short return visit (20+ min) | 243 | $16,676 | $51 |
| Professional service for single injection of allergen | 119 | $13,030 | $6 |
| Professional service for multiple injections of allergen | 53 | $6,886 | $8 |
| New patient visit (30+ min) | 66 | $4,971 | $75 |
| New patient visit (45+ min) | 37 | $4,081 | $110 |
| Test for allergy using allergenic extract injected into skin | 88 | $3,928 | $6 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 40 | $2,593 | $45 |
| Administration of influenza virus vaccine | 58 | $966 | $17 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 58 | $853 | $15 |
2013: 11 services
| Test for allergy using allergenic extract | 80 | $31,797 | $5 |
| Professional service for preparation and provision of 1 or more antigens | 114 | $19,524 | $10 |
| Short return visit (20+ min) | 184 | $11,226 | $49 |
| Professional service for single injection of allergen | 92 | $11,112 | $7 |
| Professional service for multiple injections of allergen | 43 | $4,578 | $7 |
| New patient visit (30+ min) | 59 | $3,928 | $67 |
| New patient visit (45+ min) | 31 | $3,573 | $115 |
| Test for allergy using allergenic extract injected into skin | 62 | $2,797 | $6 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 32 | $2,120 | $45 |
| Administration of influenza virus vaccine | 47 | $783 | $17 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 47 | $664 | $14 |
Medicaid work
$41,590 in 2024
Medicaid paid $41,590 for 1,746 billed services this clinician did in 2024, up to 57 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| ANTIGEN THERAPY SERVICES | 50 | $15,485 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 320 | $8,297 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 86 | $6,193 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 871 | $5,132 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 27 | $2,113 |
| Short return visit (20+ min) | 82 | $1,798 |
| Return visit (30+ min) | 35 | $1,059 |
| Nitric oxide expired gas determination | 26 | $553 |
| OFF/OP EST MAY X REQ PHY/QHP | 59 | $429 |
| IMMUNOTHERAPY ONE INJECTION | 177 | $346 |
| Respiratory flow volume loop | 13 | $186 |
| 2024 | 1,746 | 11 | 57 | $41,590 |
| 2023 | 1,969 | 9 | 69 | $43,120 |
| 2022 | 1,774 | 8 | 67 | $40,953 |
| 2021 | 2,272 | 9 | 70 | $38,291 |
| 2020 | 1,382 | 6 | 43 | $17,350 |
| 2019 | 1,596 | 6 | 53 | $35,708 |
| 2018 | 1,194 | 4 | 55 | $28,003 |
See the largest Medicaid services in earlier years
2023
| ANTIGEN THERAPY SERVICES | 28 | $13,634 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 276 | $7,903 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 1,121 | $6,574 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 64 | $5,134 |
| Return visit (30+ min) | 132 | $4,309 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 39 | $2,761 |
| Short return visit (20+ min) | 97 | $2,176 |
| IMMUNOTHERAPY ONE INJECTION | 200 | $322 |
| Nitric oxide expired gas determination | 12 | $307 |
2022
| ANTIGEN THERAPY SERVICES | 39 | $14,520 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 114 | $9,170 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 1,113 | $5,400 |
| Return visit (30+ min) | 164 | $4,848 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 65 | $3,555 |
| Short return visit (20+ min) | 147 | $2,574 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 19 | $639 |
| IMMUNOTHERAPY ONE INJECTION | 113 | $246 |
2021
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 194 | $12,771 |
| ANTIGEN THERAPY SERVICES | 21 | $7,990 |
| Return visit (30+ min) | 308 | $5,797 |
| Short return visit (20+ min) | 294 | $4,494 |
| IMMUNOTHERAPY ONE INJECTION | 1,155 | $2,820 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 24 | $1,497 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 232 | $1,409 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 13 | $1,099 |
| Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic | 31 | $414 |
2020
| ANTIGEN THERAPY SERVICES | 19 | $5,191 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 113 | $4,106 |
| Return visit (30+ min) | 114 | $2,704 |
| Short return visit (20+ min) | 211 | $2,605 |
| IMMUNOTHERAPY ONE INJECTION | 884 | $1,687 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 41 | $1,057 |
2019
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 218 | $14,626 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 183 | $10,474 |
| Short return visit (20+ min) | 392 | $6,411 |
| Return visit (30+ min) | 73 | $1,603 |
| IMMUNOTHERAPY ONE INJECTION | 639 | $1,360 |
| Respiratory flow volume loop | 91 | $1,235 |
2018
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 176 | $10,659 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 170 | $9,261 |
| Short return visit (20+ min) | 372 | $6,504 |
| IMMUNOTHERAPY ONE INJECTION | 476 | $1,580 |
Drugs they prescribed that Part D paid
$1,225,168
Pharmacies billed $1,225,168 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,320 generic and fewer than 11 brand-name prescriptions · $1,225,168 in drug cost · 31 antibiotic prescriptions to 25 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | None | 73 | $306,236 | $4,195 |
| Xolair | None | 70 | $195,687 | $2,796 |
| Gammaplex | Immune globulin | 24 | $176,103 | $7,338 |
| Tezspire | None | 37 | $142,367 | $3,848 |
| Trelegy Ellipta | None | 120 | $92,258 | $769 |
See all 36 drugs
| Dupixent | None | 73 | $306,236 | $4,195 |
| Xolair | None | 70 | $195,687 | $2,796 |
| Gammaplex | Immune globulin | 24 | $176,103 | $7,338 |
| Tezspire | None | 37 | $142,367 | $3,848 |
| Trelegy Ellipta | None | 120 | $92,258 | $769 |
| Spiriva Respimat | None | 33 | $32,721 | $992 |
| Breo Ellipta | None | 42 | $20,512 | $488 |
| Ipratropium | None | 256 | $13,751 | $54 |
| Anoro Ellipta | None | 23 | $13,029 | $566 |
| Alvesco | None | 17 | $11,470 | $675 |
| Advair Hfa | None | 22 | $11,270 | $512 |
| Qvar Redihaler | None | 20 | $10,927 | $546 |
| Symbicort | None | 33 | $10,053 | $305 |
| Fluticasone-Salmeterol | None | 53 | $9,091 | $172 |
| Dulera | None | 23 | $8,275 | $360 |
| Fluticasone Propionate Hfa | None | 22 | $7,203 | $327 |
| Advair Diskus | None | 19 | $5,667 | $298 |
| Breyna | None | 24 | $5,459 | $227 |
| Azelastine | None | 163 | $4,983 | $31 |
| Albuterol Sulfate Hfa | None | 155 | $4,571 | $29 |
| Arnuity Ellipta | None | 17 | $4,316 | $254 |
| Mometasone Furoate | None | 29 | $3,376 | $116 |
| Azelastine-Fluticasone | None | 27 | $2,812 | $104 |
| Wixela Inhub | None | 32 | $2,553 | $80 |
| Levocetirizine Dihydrochloride | None | 113 | $2,097 | $19 |
| Epinephrine | None | 14 | $2,053 | $147 |
| Montelukast | None | 204 | $2,033 | $10 |
| Ventolin Hfa | None | 31 | $1,867 | $60 |
| Fluticasone Propionate | None | 81 | $1,677 | $21 |
| Levalbuterol Tartrate Hfa | None | 34 | $1,620 | $48 |
| Pantoprazole | None | 17 | $276 | $16 |
| Trazodone | None | 12 | $203 | $17 |
| Prednisone | None | 40 | $150 | $4 |
| Amoxicillin-Clavulanate Potass | None | 13 | $106 | $8 |
| Hydrochlorothiazide | None | 12 | $36 | $3 |
| Alprazolam | None | 13 | $4 | $0 |
Year by year
| 2024 | 2,246 | 427 | None | None | $1,225,168 |
| 2023 | 2,212 | 413 | None | None | $1,593,035 |
| 2022 | 2,269 | 400 | 0% (0) | None | $1,617,821 |
| 2021 | 2,154 | 399 | 0% (0) | 44% | $1,394,824 |
| 2020 | 1,383 | 253 | 0% (0) | 45% | $1,077,612 |
| 2019 | 1,379 | 257 | 0% (0) | 39% | $907,120 |
| 2018 | 940 | 257 | 0% (0) | 34% | $380,244 |
| 2017 | 629 | 215 | 0% (0) | 33% | $117,212 |
| 2016 | 785 | 245 | 0% (0) | 30% | $110,437 |
| 2015 | 781 | 255 | None | 33% | $101,044 |
| 2014 | 845 | 237 | 0% (0) | 31% | $116,092 |
| 2013 | 581 | 171 | None | 38% | $91,372 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 35 drugs
| Dupixent | None | 50 | $238,030 | $4,761 |
| Xolair | None | 76 | $236,230 | $3,108 |
| Gammaplex | Immune globulin | 25 | $188,790 | $7,552 |
| Tezspire | None | 30 | $133,280 | $4,443 |
| Trelegy Ellipta | None | 104 | $93,690 | $901 |
| Nucala | None | 16 | $60,062 | $3,754 |
| Spiriva Respimat | None | 60 | $47,206 | $787 |
| Symbicort | None | 64 | $33,000 | $516 |
| Breo Ellipta | None | 46 | $29,863 | $649 |
| Advair Hfa | None | 37 | $27,393 | $740 |
| Alvesco | None | 22 | $18,162 | $826 |
| Flovent Hfa | None | 28 | $14,613 | $522 |
| Advair Diskus | None | 26 | $14,432 | $555 |
| Ipratropium | None | 252 | $13,460 | $53 |
| Qvar Redihaler | None | 26 | $12,484 | $480 |
| Fluticasone-Salmeterol | None | 44 | $11,425 | $260 |
| Anoro Ellipta | None | 19 | $11,148 | $587 |
| Serevent Diskus | None | 17 | $10,384 | $611 |
| Dulera | None | 36 | $10,292 | $286 |
| Azelastine | None | 161 | $8,248 | $51 |
| Arnuity Ellipta | None | 17 | $5,447 | $320 |
| Epinephrine | None | 25 | $4,715 | $189 |
| Montelukast | None | 224 | $3,986 | $18 |
| Albuterol Sulfate Hfa | None | 116 | $3,555 | $31 |
| Mometasone Furoate | None | 21 | $3,276 | $156 |
| Levalbuterol Tartrate Hfa | None | 55 | $3,222 | $59 |
| Levocetirizine Dihydrochloride | None | 119 | $2,968 | $25 |
| Azelastine-Fluticasone | None | 21 | $2,652 | $126 |
| Wixela Inhub | None | 16 | $2,639 | $165 |
| Ventolin Hfa | None | 37 | $2,589 | $70 |
| Fluticasone Propionate | None | 92 | $1,578 | $17 |
| Olopatadine | None | 15 | $922 | $61 |
| Prednisone | None | 53 | $359 | $7 |
| Omeprazole | None | 11 | $280 | $25 |
| Triamcinolone Acetonide | None | 14 | $183 | $13 |
2022: 34 drugs
| Haegarda | None | 13 | $457,209 | $35,170 |
| Xolair | None | 79 | $222,063 | $2,811 |
| Dupixent | None | 33 | $163,531 | $4,955 |
| Gammaplex | Immune globulin | 18 | $132,012 | $7,334 |
| Nucala | None | 19 | $68,922 | $3,627 |
| Trelegy Ellipta | None | 77 | $65,296 | $848 |
| Spiriva Respimat | None | 74 | $56,109 | $758 |
| Symbicort | None | 93 | $49,848 | $536 |
| Advair Hfa | None | 46 | $27,736 | $603 |
| Breo Ellipta | None | 44 | $26,329 | $598 |
| Advair Diskus | None | 41 | $25,388 | $619 |
| Anoro Ellipta | None | 35 | $20,829 | $595 |
| Flovent Hfa | None | 25 | $18,450 | $738 |
| Dulera | None | 37 | $18,245 | $493 |
| Alvesco | None | 39 | $18,005 | $462 |
| Ipratropium | None | 214 | $12,512 | $58 |
| Qvar Redihaler | None | 30 | $10,558 | $352 |
| Wixela Inhub | None | 33 | $10,154 | $308 |
| Azelastine | None | 194 | $9,485 | $49 |
| Serevent Diskus | None | 13 | $7,792 | $599 |
| Fluticasone-Salmeterol | None | 27 | $6,828 | $253 |
| Arnuity Ellipta | None | 17 | $6,133 | $361 |
| Albuterol Sulfate Hfa | None | 114 | $5,234 | $46 |
| Montelukast | None | 259 | $4,796 | $19 |
| Epinephrine | None | 18 | $4,504 | $250 |
| Levocetirizine Dihydrochloride | None | 129 | $3,721 | $29 |
| Azelastine-Fluticasone | None | 24 | $3,523 | $147 |
| Levalbuterol Tartrate Hfa | None | 48 | $3,204 | $67 |
| Ventolin Hfa | None | 40 | $2,710 | $68 |
| Fluticasone Propionate | None | 107 | $1,924 | $18 |
| Desloratadine | None | 13 | $1,464 | $113 |
| Prednisone | None | 64 | $528 | $8 |
| Pantoprazole | None | 26 | $267 | $10 |
| Omeprazole | None | 15 | $240 | $16 |
2021: 39 drugs
| Haegarda | None | 20 | $503,648 | $25,182 |
| Dupixent | None | 48 | $184,370 | $3,841 |
| Gammaplex | Immune globulin | 23 | $153,662 | $6,681 |
| Xolair | None | 40 | $112,357 | $2,809 |
| Symbicort | None | 92 | $52,823 | $574 |
| Trelegy Ellipta | None | 69 | $50,997 | $739 |
| Spiriva Respimat | None | 77 | $47,341 | $615 |
| Advair Hfa | None | 48 | $32,217 | $671 |
| Breo Ellipta | None | 48 | $24,180 | $504 |
| Advair Diskus | None | 28 | $15,693 | $560 |
| Qvar Redihaler | None | 43 | $14,040 | $327 |
| Flovent Hfa | None | 16 | $12,784 | $799 |
| Wixela Inhub | None | 37 | $12,408 | $335 |
| Azelastine | None | 197 | $10,899 | $55 |
| Ipratropium | None | 185 | $10,552 | $57 |
| Anoro Ellipta | None | 21 | $9,678 | $461 |
| Dulera | None | 16 | $8,643 | $540 |
| Alvesco | None | 16 | $7,030 | $439 |
| Budesonide-Formoterol | None | 18 | $6,580 | $366 |
| Albuterol Sulfate Hfa | None | 134 | $6,219 | $46 |
| Epinephrine | None | 23 | $6,001 | $261 |
| Incruse Ellipta | None | 11 | $4,095 | $372 |
| Azelastine-Fluticasone | None | 22 | $4,011 | $182 |
| Fluticasone-Salmeterol | None | 18 | $3,906 | $217 |
| Levocetirizine Dihydrochloride | None | 131 | $3,509 | $27 |
| Levalbuterol Tartrate Hfa | None | 52 | $3,261 | $63 |
| Montelukast | None | 237 | $2,615 | $11 |
| Olopatadine | None | 32 | $2,470 | $77 |
| Ventolin Hfa | None | 26 | $2,309 | $89 |
| Mometasone Furoate | None | 13 | $1,928 | $148 |
| Fluticasone Propionate | None | 90 | $1,636 | $18 |
| Esomeprazole Magnesium | None | 12 | $1,481 | $123 |
| Prednisone | None | 53 | $377 | $7 |
| Omeprazole | None | 16 | $268 | $17 |
| Clobetasol Propionate | None | 12 | $238 | $20 |
| Hydroxyzine | None | 20 | $226 | $11 |
| Azithromycin | None | 18 | $131 | $7 |
| Pantoprazole | None | 12 | $98 | $8 |
| Triamcinolone Acetonide | None | 11 | $62 | $6 |
2020: 26 drugs
| Haegarda | 26 | $535,086 | $20,580 |
| Dupixent | 54 | $198,519 | $3,676 |
| Symbicort | 84 | $43,864 | $522 |
| Xolair | 14 | $33,005 | $2,357 |
| Advair Hfa | 54 | $30,557 | $566 |
| Trelegy Ellipta | 41 | $23,445 | $572 |
| Breo Ellipta | 46 | $22,631 | $492 |
| Spiriva Respimat | 25 | $11,573 | $463 |
| Incruse Ellipta | 24 | $8,581 | $358 |
| Azelastine | 150 | $7,766 | $52 |
| Qvar Redihaler | 19 | $6,955 | $366 |
| Ipratropium | 103 | $6,517 | $63 |
| Spiriva | 13 | $6,221 | $479 |
| Wixela Inhub | 25 | $6,055 | $242 |
| Flovent Hfa | 16 | $5,626 | $352 |
| Budesonide-Formoterol | 16 | $4,734 | $296 |
| Levocetirizine Dihydrochloride | 110 | $3,291 | $30 |
| Epinephrine | 11 | $3,092 | $281 |
| Albuterol Sulfate Hfa | 60 | $2,773 | $46 |
| Montelukast | 168 | $2,086 | $12 |
| Olopatadine | 18 | $2,043 | $114 |
| Xopenex Hfa | 21 | $1,483 | $71 |
| Ventolin Hfa | 18 | $1,046 | $58 |
| Fluticasone Propionate | 43 | $857 | $20 |
| Prednisone | 34 | $141 | $4 |
| Azithromycin | 13 | $94 | $7 |
2019: 30 drugs
| Haegarda | 26 | $523,016 | $20,116 |
| Dupixent | 46 | $144,497 | $3,141 |
| Breo Ellipta | 66 | $27,747 | $420 |
| Xolair | 12 | $26,572 | $2,214 |
| Symbicort | 56 | $25,618 | $457 |
| Advair Hfa | 44 | $23,705 | $539 |
| Spiriva Respimat | 25 | $11,007 | $440 |
| Advair Diskus | 23 | $10,857 | $472 |
| Ipratropium | 148 | $6,656 | $45 |
| Incruse Ellipta | 19 | $6,621 | $348 |
| Trelegy Ellipta | 12 | $6,413 | $534 |
| Qvar Redihaler | 18 | $5,891 | $327 |
| Azelastine | 138 | $5,715 | $41 |
| Epinephrine | 12 | $4,038 | $336 |
| Dulera | 12 | $3,628 | $302 |
| Wixela Inhub | 13 | $2,958 | $228 |
| Ventolin Hfa | 44 | $2,553 | $58 |
| Mometasone Furoate | 13 | $2,224 | $171 |
| Fluticasone-Salmeterol | 14 | $2,148 | $153 |
| Montelukast | 193 | $2,107 | $11 |
| Olopatadine | 11 | $1,145 | $104 |
| Fluticasone Propionate | 82 | $1,129 | $14 |
| Proair Hfa | 13 | $860 | $66 |
| Levocetirizine Dihydrochloride | 47 | $789 | $17 |
| Albuterol Sulfate Hfa | 11 | $511 | $46 |
| Amoxicillin-Clavulanate Potass | 21 | $330 | $16 |
| Prednisone | 86 | $309 | $4 |
| Doxepin | 13 | $257 | $20 |
| Triamcinolone Acetonide | 17 | $142 | $8 |
| Azithromycin | 15 | $125 | $8 |
2018: 21 drugs
| Haegarda | 12 | $228,646 | $19,054 |
| Xolair | 12 | $26,257 | $2,188 |
| Advair Diskus | 45 | $19,718 | $438 |
| Advair Hfa | 22 | $12,387 | $563 |
| Symbicort | 29 | $11,736 | $405 |
| Breo Ellipta | 23 | $11,255 | $489 |
| Ipratropium | 124 | $5,197 | $42 |
| Epinephrine | 15 | $4,334 | $289 |
| Azelastine | 87 | $4,286 | $49 |
| Betamethasone Dipropionate | 19 | $2,099 | $110 |
| Ventolin Hfa | 30 | $1,635 | $54 |
| Montelukast | 130 | $1,337 | $10 |
| Olopatadine | 12 | $1,128 | $94 |
| Proair Hfa | 17 | $1,053 | $62 |
| Fluticasone Propionate | 63 | $976 | $15 |
| Levocetirizine Dihydrochloride | 33 | $417 | $13 |
| Doxepin | 18 | $402 | $22 |
| Prednisone | 59 | $210 | $4 |
| Triamcinolone Acetonide | 11 | $125 | $11 |
| Hydroxyzine | 13 | $80 | $6 |
| Azithromycin | 14 | $78 | $6 |
2017: 14 drugs
| Advair Diskus | 18 | $11,047 | $614 |
| Flovent Hfa | 30 | $8,864 | $295 |
| Symbicort | 15 | $5,239 | $349 |
| Breo Ellipta | 15 | $5,170 | $345 |
| Proair Hfa | 32 | $3,177 | $99 |
| Ipratropium | 81 | $2,749 | $34 |
| Azelastine | 53 | $2,470 | $47 |
| Ventolin Hfa | 21 | $1,283 | $61 |
| Fluticasone Propionate | 60 | $1,001 | $17 |
| Montelukast | 58 | $747 | $13 |
| Levocetirizine Dihydrochloride | 42 | $700 | $17 |
| Prednisone | 58 | $179 | $3 |
| Azithromycin | 13 | $87 | $7 |
| Hydroxyzine | 15 | $81 | $5 |
2016: 17 drugs
| Zyflo Cr | 12 | $37,938 | $3,161 |
| Advair Diskus | 26 | $13,137 | $505 |
| Symbicort | 29 | $9,325 | $322 |
| Flovent Hfa | 33 | $7,956 | $241 |
| Spiriva | 12 | $4,077 | $340 |
| Azelastine | 89 | $3,567 | $40 |
| Clobetasol Propionate | 16 | $2,948 | $184 |
| Proair Hfa | 34 | $2,385 | $70 |
| Fluticasone Propionate | 79 | $1,525 | $19 |
| Ipratropium | 49 | $1,374 | $28 |
| Levocetirizine Dihydrochloride | 76 | $1,368 | $18 |
| Ventolin Hfa | 13 | $674 | $52 |
| Montelukast | 42 | $666 | $16 |
| Hydroxyzine | 30 | $276 | $9 |
| Prednisone | 80 | $243 | $3 |
| Doxepin | 11 | $176 | $16 |
| Triamcinolone Acetonide | 15 | $151 | $10 |
2015: 18 drugs
| Symbicort | 39 | $11,118 | $285 |
| Advair Diskus | 11 | $7,155 | $650 |
| Clobetasol Propionate | 34 | $6,079 | $179 |
| Azelastine | 119 | $5,519 | $46 |
| Qvar | 23 | $4,289 | $186 |
| Pulmicort Flexhaler | 21 | $4,218 | $201 |
| Spiriva | 11 | $3,448 | $313 |
| Pataday | 11 | $1,848 | $168 |
| Proair Hfa | 29 | $1,667 | $57 |
| Fluticasone Propionate | 113 | $1,273 | $11 |
| Levocetirizine Dihydrochloride | 44 | $1,113 | $25 |
| Ipratropium | 40 | $1,032 | $26 |
| Hydroxyzine | 30 | $401 | $13 |
| Montelukast | 20 | $297 | $15 |
| Theophylline Anhydrous | 13 | $278 | $21 |
| Prednisone | 76 | $276 | $4 |
| Amoxicillin-Clavulanate Potass | 15 | $211 | $14 |
| Azithromycin | 23 | $172 | $7 |
2014: 17 drugs
| Azelastine | 141 | $8,117 | $58 |
| Symbicort | 27 | $7,058 | $261 |
| Advair Hfa | 14 | $5,696 | $407 |
| Spiriva | 14 | $5,555 | $397 |
| Qvar | 22 | $4,694 | $213 |
| Fluticasone Propionate | 172 | $3,059 | $18 |
| Pulmicort Flexhaler | 17 | $2,953 | $174 |
| Clobetasol Propionate | 22 | $2,118 | $96 |
| Levocetirizine Dihydrochloride | 42 | $1,605 | $38 |
| Proair Hfa | 22 | $1,510 | $69 |
| Montelukast | 32 | $660 | $21 |
| Ipratropium | 24 | $585 | $24 |
| Hydroxyzine | 32 | $391 | $12 |
| Prednisone | 96 | $326 | $3 |
| Theophylline Anhydrous | 12 | $188 | $16 |
| Amox Tr-Potassium Clavulanate | 11 | $171 | $16 |
| Azithromycin | 13 | $106 | $8 |
2013: 15 drugs
| Advair Hfa | 19 | $6,596 | $347 |
| Symbicort | 23 | $6,399 | $278 |
| Qvar | 24 | $4,923 | $205 |
| Azelastine | 61 | $4,191 | $69 |
| Fluticasone Propionate | 115 | $3,255 | $28 |
| Nasonex | 14 | $2,879 | $206 |
| Pulmicort Flexhaler | 12 | $1,984 | $165 |
| Proair Hfa | 26 | $1,708 | $66 |
| Montelukast | 11 | $1,248 | $113 |
| Triamcinolone Acetonide | 18 | $1,060 | $59 |
| Ipratropium | 27 | $717 | $27 |
| Clobetasol Propionate | 16 | $609 | $38 |
| Hydroxyzine | 37 | $524 | $14 |
| Theophylline Anhydrous | 16 | $318 | $20 |
| Prednisone | 22 | $68 | $3 |
Money from drug and device companies
$4,313 in 2025
| 2025 | 23 | 106 | $1,666 | $4,313 |
| 2024 | 21 | 80 | $900 | $3,424 |
| 2023 | 22 | 98 | $119 | $2,807 |
| 2022 | 18 | 78 | $5,000 | $8,496 |
| 2021 | 22 | 77 | $1,375 | $3,106 |
| 2020 | 15 | 26 | $800 | $1,478 |
| 2019 | 14 | 41 | None | $1,162 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genentech USA | Xolair | $1,708 | 5 payments
|
| Genzyme | Dupixent | $700 | 24 payments
|
| Novartis Pharmaceuticals | Rhapsido | $216 | 8 payments
|
| GlaxoSmithKline | Nucala | $183 | 16 payments
|
| AstraZeneca Pharmaceuticals LP | Airsupra | $181 | 8 payments
|
| CSL Behring | Andembry | $174 | 4 payments
|
See all 105 published payments
| Genzyme | Meals · 2025-12-19 | Dupixent | $100 |
| GlaxoSmithKline | Meals · 2025-12-09 | Trelegy Ellipta | $12 |
| Genzyme | Meals · 2025-12-09 | Dupixent | $12 |
| GlaxoSmithKline | Meals · 2025-12-04 | Nucala | $23 |
| Genzyme | Meals · 2025-12-01 | Dupixent | $10 |
| Sanofi-Aventis U.S. | Education · 2025-12-01 | Dupixent | $100 |
| Ionis Pharmaceuticals | Meals · 2025-11-19 | Dawnzera | $27 |
| Novartis Pharmaceuticals | Meals · 2025-11-18 | Rhapsido | $22 |
| BioCryst US Sales Co. | Meals · 2025-11-13 | Orladeyo | $29 |
| GlaxoSmithKline | Meals · 2025-11-12 | Nucala | $7 |
| Galderma Laboratories L.P. | Meals · 2025-11-12 | Nemluvio | $29 |
| GlaxoSmithKline | Meals · 2025-11-11 | Nucala | $2 |
| GlaxoSmithKline | Meals · 2025-11-10 | Nucala | $8 |
| Amgen | Meals · 2025-11-06 | Tezspire | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-11-05 | Dupixent | $30 |
| Amgen | Meals · 2025-11-05 | Tezspire | $13 |
| Teva Pharmaceuticals USA | Meals · 2025-11-05 | Albuterol Sulfate | $26 |
| Genzyme | Meals · 2025-10-28 | Dupixent | $28 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-10-27 | Eohilia | $27 |
| CSL Behring | Meals · 2025-10-27 | Andembry | $114 |
| Genzyme | Meals · 2025-10-20 | Dupixent | $7 |
| Novartis Pharmaceuticals | Meals · 2025-10-16 | Rhapsido | $33 |
| Genentech USA | Meals · 2025-10-13 | Xolair | $24 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-10-08 | Cuvitru | $27 |
| Genzyme | Meals · 2025-10-06 | Dupixent | $28 |
| Organon | Meals · 2025-10-01 | None | $31 |
| Genzyme | Meals · 2025-09-29 | Dupixent | $11 |
| Genzyme | Meals · 2025-09-25 | Dupixent | $7 |
| Ionis Pharmaceuticals | Meals · 2025-09-16 | Dawnzera | $21 |
| Novartis Pharmaceuticals | Meals · 2025-09-15 | None | $24 |
| Grifols USA | Meals · 2025-09-10 | Xembify | $33 |
| Regeneron Healthcare Solutions | Meals · 2025-09-03 | Dupixent | $29 |
| CSL Behring | Meals · 2025-08-27 | Andembry | $12 |
| BioCryst US Sales Co. | Meals · 2025-08-25 | Orladeyo | $22 |
| GlaxoSmithKline | Meals · 2025-08-19 | Nucala | $26 |
| GlaxoSmithKline | Meals · 2025-08-19 | Nucala | $0 |
| Novartis Pharmaceuticals | Meals · 2025-08-19 | None | $3 |
| Genzyme | Meals · 2025-08-18 | Dupixent | $9 |
| GlaxoSmithKline | Meals · 2025-08-17 | Trelegy Ellipta | $9 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-14 | Tezspire | $20 |
| Optinose US | Meals · 2025-08-13 | Xhance | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-12 | None | $28 |
| Genzyme | Meals · 2025-08-11 | Dupixent | $28 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-08-04 | Eohilia | $26 |
| Genzyme | Meals · 2025-07-30 | Dupixent | $24 |
| Genzyme | Meals · 2025-07-30 | Dupixent | $12 |
| Teva Pharmaceuticals USA | Meals · 2025-07-29 | Albuterol Sulfate | $27 |
| Genentech USA | Consulting · 2025-07-26 | Xolair | $1,605 |
| GlaxoSmithKline | Meals · 2025-07-24 | Nucala | $6 |
| GlaxoSmithKline | Meals · 2025-07-23 | Nucala | $6 |
| GlaxoSmithKline | Meals · 2025-07-23 | Nucala | $0 |
| Amgen | Meals · 2025-07-21 | Tezspire | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-18 | None | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-16 | None | $21 |
| CSL Behring | Meals · 2025-06-24 | Haegarda | $19 |
| Genzyme | Meals · 2025-06-23 | Dupixent | $11 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-06-18 | Cuvitru | $30 |
| Genzyme | Meals · 2025-06-10 | Dupixent | $10 |
| Genzyme | Meals · 2025-06-09 | Dupixent | $130 |
| Grifols USA | Meals · 2025-06-06 | Xembify | $24 |
| Novartis Pharmaceuticals | Meals · 2025-05-30 | None | $73 |
| Novartis Pharmaceuticals | Meals · 2025-05-28 | None | $31 |
| Amgen | Meals · 2025-05-21 | Tezspire | $27 |
| Kowa Pharmaceuticals America | Meals · 2025-05-19 | Zoryve | $21 |
| Genzyme | Meals · 2025-05-16 | Dupixent | $47 |
| Regeneron Pharmaceuticals | Meals · 2025-05-15 | Dupixent | $30 |
| Novartis Pharmaceuticals | Meals · 2025-05-08 | None | $3 |
| Novartis Pharmaceuticals | Meals · 2025-05-08 | None | $28 |
| GlaxoSmithKline | Meals · 2025-05-07 | Nucala | $28 |
| Genzyme | Meals · 2025-04-30 | Dupixent | $32 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-24 | Airsupra | $30 |
| Amgen | Meals · 2025-04-23 | Tezspire | $25 |
| Genzyme | Meals · 2025-04-23 | Dupixent | $100 |
| Genentech USA | Meals · 2025-04-09 | Xolair | $28 |
| Regeneron Healthcare Solutions | Meals · 2025-04-08 | Dupixent | $18 |
| Genzyme | Meals · 2025-04-08 | Dupixent | $9 |
| Pharming Healthcare | Meals · 2025-04-03 | Ruconest | $25 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-04-02 | Eohilia | $26 |
| Teva Pharmaceuticals USA | Meals · 2025-04-02 | Albuterol Sulfate | $32 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-01 | Airsupra | $23 |
| CSL Behring | Meals · 2025-03-31 | Haegarda | $30 |
| GlaxoSmithKline | Meals · 2025-03-25 | Trelegy Ellipta | $5 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-03-25 | Gammagard | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-19 | Fasenra | $25 |
| Genentech USA | Meals · 2025-03-17 | Xolair | $32 |
| Genzyme | Meals · 2025-03-12 | Dupixent | $22 |
| BioCryst US Sales Co. | Meals · 2025-03-10 | Orladeyo | $24 |
| Amgen | Meals · 2025-02-26 | Tezspire | $25 |
| GlaxoSmithKline | Meals · 2025-02-24 | Nucala | $11 |
| Optinose US | Meals · 2025-02-19 | Xhance | $25 |
| GlaxoSmithKline | Meals · 2025-02-18 | Nucala | $15 |
| ADMA BioManufacturing | Consulting · 2025-02-12 | None | $61 |
| Genentech | Meals · 2025-02-11 | Xolair | $31 |
| Amgen | Meals · 2025-02-06 | Actimmune | $26 |
| Genzyme | Meals · 2025-02-06 | Dupixent | $15 |
| Genzyme | Meals · 2025-02-05 | Dupixent | $31 |
| Organon | Meals · 2025-02-04 | Vtama | $31 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-27 | Fasenra | $14 |
| Regeneron Healthcare Solutions | Meals · 2025-01-22 | Dupixent | $21 |
| Lilly USA | Meals · 2025-01-21 | Ebglyss | $23 |
| BioCryst US Sales Co. | Meals · 2025-01-15 | Orladeyo | $28 |
| Genzyme | Meals · 2025-01-13 | Dupixent | $8 |
| GlaxoSmithKline | Meals · 2025-01-08 | Nucala | $25 |
| Genentech USA | Meals · 2025-01-08 | Xolair | $19 |
| Genzyme | Meals · 2025-01-08 | Dupixent | $8 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,424
| Genzyme | Dupixent | $1,641 | 18 payments
|
| AstraZeneca Pharmaceuticals LP | Tezspire | $429 | 12 payments
|
| Genentech USA | Xolair | $187 | 8 payments
|
| Amgen | Tezspire | $186 | 6 payments
|
| ADMA BioManufacturing | None | $170 | 2 payments
|
| CSL Behring | Hizentra | $105 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $88 | 4 payments
|
| Novartis Pharmaceuticals | Xolair | $80 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Hyqvia | $80 | 3 payments
|
| Grifols USA | Xembify | $69 | 4 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $57 | 2 payments
|
| Optinose US | Xhance | $46 | 2 payments
|
| Phadia US | Immunocap | $43 | 2 payments
|
| Electromed | Smartvest | $41 | 2 payments
|
| BioCryst US Sales Co. | Orladeyo | $40 | 2 payments
|
| Medline Industries LP | Medline Industries, Inc. | $37 | 1 payment
|
| Pharming Healthcare | Ruconest | $30 | 1 payment
|
| Lilly USA | Ebglyss | $27 | 1 payment
|
| Pfizer | Panzyga | $24 | 1 payment
|
| kaleo | Auvi-Q | $23 | 1 payment
|
| Dermavant Sciences | Vtama | $23 | 1 payment
|
2023: $2,807
| AstraZeneca Pharmaceuticals LP | Tezspire | $439 | 10 payments
|
| Grifols USA | Xembify | $339 | 7 payments
|
| Genzyme | Dupixent | $310 | 11 payments
|
| Regeneron Healthcare Solutions | Dupixent | $221 | 5 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $175 | 11 payments
|
| Genentech USA | Xolair | $163 | 7 payments
|
| CSL Behring | Hizentra | $138 | 6 payments
|
| Pfizer | Panzyga | $129 | 9 payments
|
| ADMA BioManufacturing | None | $119 | 2 payments
|
| Bio Products Laboratory USA | Gammaplex | $110 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $107 | 4 payments
|
| Boston Scientific | None | $103 | 1 payment
|
| AbbVie | Rinvoq | $93 | 4 payments
|
| BioCryst US Sales Co. | Orladeyo | $68 | 4 payments
|
| Amgen | Tezspire | $57 | 2 payments
|
| Novartis Pharmaceuticals | Xolair | $53 | 2 payments
|
| Optinose US | Xhance | $45 | 2 payments
|
| Octapharma USA | Cutaquig | $44 | 2 payments
|
| Merck Sharp & Dohme | None | $26 | 1 payment
|
| Blueprint Medicines | Ayvakit | $24 | 1 payment
|
| Inspire Medical Systems | Inspire | $23 | 1 payment
|
| ALK-Abello | Odactra | $21 | 1 payment
|
2022: $8,496
| Bio Products Laboratory USA | Gammaplex | $6,630 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $483 | 10 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $236 | 10 payments
|
| Genentech USA | Xolair | $158 | 7 payments
|
| Amgen | Tezspire | $135 | 3 payments
|
| Abbvie | Rinvoq | $123 | 9 payments
|
| Genzyme | Dupixent | $104 | 2 payments
|
| OptiNose US | Xhance | $82 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $72 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Hyqvia | $71 | 3 payments
|
| Grifols USA | Xembify | $70 | 3 payments
|
| Pfizer | Cibinqo | $70 | 3 payments
|
| Aimmune Therapeutics | Palforzia | $69 | 3 payments
|
| CSL Behring | Hizentra | $69 | 3 payments
|
| BioCryst US Sales Co. | Orladeyo | $51 | 2 payments
|
| ALK-Abello | Odactra | $25 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $24 | 1 payment
|
| kaleo | Auvi-Q | $24 | 1 payment
|
2021: $3,106
| Genentech USA | Xolair | $1,526 | 10 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $294 | 10 payments
|
| Regeneron Healthcare Solutions | Dupixent | $175 | 3 payments
|
| Genzyme | Dupixent | $172 | 4 payments
|
| CSL Behring | Hizentra | $142 | 15 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $118 | 5 payments
|
| Teva Pharmaceuticals USA | Airduo Digihaler | $98 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $97 | 5 payments
|
| ALK-Abello | Odactra | $85 | 2 payments
|
| Optinose US | Xhance | $83 | 4 payments
|
| Grifols USA | Xembify | $55 | 2 payments
|
| BioCryst US Sales Co. | Orladeyo | $50 | 2 payments
|
| Pfizer | Panzyga | $40 | 2 payments
|
| Ucb | Briviact | $28 | 1 payment
|
| Cardiovascular Systems | Diamondback Peripheral | $23 | 1 payment
|
| Novartis Pharmaceuticals | None | $23 | 1 payment
|
| Bio Products Laboratory USA | Gammaplex | $22 | 1 payment
|
| Merck Sharp & Dohme | None | $19 | 1 payment
|
| Octapharma USA | Cutaquig | $15 | 1 payment
|
| kaleo | Auvi-Q | $15 | 1 payment
|
| Aimmune Therapeutics | Palforzia | $14 | 1 payment
|
| Circassia | Niox | $11 | 1 payment
|
2020: $1,478
| OptiNose US | Xhance | $837 | 3 payments
|
| Genzyme | Dupixent | $125 | 1 payment
|
| Pfizer | Eucrisa | $123 | 6 payments
|
| ALK-Abello | Odactra | $69 | 1 payment
|
| CSL Behring | Haegarda | $62 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $48 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $39 | 2 payments
|
| kaleo | Auvi-Q | $29 | 1 payment
|
| Teva Pharmaceuticals USA | Airduo Digihaler | $29 | 1 payment
|
| Bio Products Laboratory USA | Gammaplex | $28 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Breztri Aerosphere | $22 | 1 payment
|
| Circassia Pharmaceuticals | Tudorza Pressair | $19 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $17 | 1 payment
|
| Genentech USA | Xolair | $17 | 1 payment
|
| Covis Pharma GmbH | Alvesco | $14 | 1 payment
|
2019: $1,162
| GlaxoSmithKline | Trelegy Ellipta | $195 | 5 payments
|
| Bio Products Laboratory USA | Gammaplex | $172 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Symbicort | $145 | 7 payments
|
| Genzyme | Dupixent | $133 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $91 | 4 payments
|
| Novartis Pharmaceuticals | Xolair | $73 | 4 payments
|
| Genentech | Xolair | $66 | 2 payments
|
| Circassia Pharmaceuticals | Tudorza Pressair | $66 | 3 payments
|
| Cardinal Health 200 | None | $60 | 2 payments
|
| OptiNose US | Xhance | $60 | 3 payments
|
| Teva Pharmaceuticals USA | Cinqair | $42 | 1 payment
|
| Pfizer | Cutaquig | $31 | 1 payment
|
| Greer Laboratories | Oralair | $15 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $12 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Teva Pharmaceuticals USA, Inc. · A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study To Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma · 2025 | Their institution | $30,536 |
| SANOFI US SERVICES INC. · Topical Corticosteroids Combo Vs Placebo Study in Pts. With Moderate To Severe Ad · 2025 | Their institution | $26,432 |
| Teva Pharmaceuticals USA, Inc. · A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study To Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma · 2024 | Their institution | $22,647 |
| Novartis Pharmaceuticals Corporation · A US Phase 3b, Multi-Center, Randomized, Double-Blind, Double-Dummy Study To Evaluate Efficacy of Remibrutinib Compared To Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled By Second Generation H1-Antihista · 2025 | Their institution | $454 |
Checkups this office reported
6 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 82.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse)As Medicare defines this measure | 0% | 43 |
| Asked about alcoholPatients screened for unhealthy alcohol use, with counseling if needed | 100%That's most of the people this applied to. | 100 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 100%That's most of the people this applied to. | 600 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 1,404 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 535 |
| Tobacco Use and Help with Quitting Among AdolescentsAs Medicare defines this measure | 100% | 126 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
- Tobacco use
Professional record
- NPI
- 1558423814
- Licence
- CA 147289California C147289: Current · expires 2027-02-28
- Trained
- Harvard Medical School, 2003 · 23 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RA0201X (207RA0201X)
- Mailing address
- 1100 Pear Tree Ln, Napa, CA, 94558
- NPI first listed
- 2006-12-14
- NPI last updated
- 2023-03-07
- NPI record certified
- 2020-02-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 414 W Napa St Ste B, Sonoma, CA, 95476